The global market for Infection Surveillance Solutions is estimated at US$670.2 Million in 2023 and is projected to reach US$1.9 Billion by 2030, growing at a CAGR of 14.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Global Infection Surveillance Solutions Market]( "Global Infection Surveillance Solutions Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Infection Surveillance Software segment, which is expected to reach US$1.2 Billion by 2030 with a CAGR of 13.7%. The Infection Surveillance Services segment is also set to grow at 15.1% CAGR for the next 8-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $237.1 Million in 2023, and China, forecasted to grow at an impressive 15.1% CAGR to reach $233.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Infection Surveillance Solutions Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infection Surveillance Solutions Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Infection Surveillance Solutions Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as IBM Corporation, Becton, Dickinson and Company, bioMerieux SA, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 40 Featured):
- IBM Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Illumina, Inc.
- Cerner Corporation
- Ecolab, Inc.
- Gojo Industries, Inc.
- Epic Systems Corporation
- CenTrak, Inc.
- Iatric Systems, Inc.
- Harris Healthcare
- Perahealth, Inc.
- ABILITY Network Inc.
- Asolva, Inc.
- ICNet International
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- A Prelude to Infection Surveillance Solutions
- Global Economic Update
- Infection Surveillance Solutions - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Market Analysis and Prospects
- Infection Surveillance Solutions Market Witnesses Steady Growth
- Surveillance Software Holds a Significant Share
- By Infection Type, UTI Holds a Strong Place
- Hospitals Account for a Major Share of the Market
- North America and Europe Hold Major Presence, Asia-Pacific to Witness Fastest Growth
3. MARKET TRENDS & DRIVERS
- Growing Prevalence of Infectious Diseases Spurs Demand for Infection Surveillance Solutions
- Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
- Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
- Rising Incidence of Hospital Acquired Infections (HAIs) Drives Market Growth
- Mitigating the Risks Associated With Hospital-Acquired Infections
- Shift to proactive From Reactive
- Initiatives for Stewardship
- Report Production
- Government Measures to Control HAIs Drive Infection Surveillance Solutions Market
- Rising Prevalence of Respiratory Infections to Drive Need for POC Molecular Diagnostics
- Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
- Infection Control Software Witnesses Steady Growth
- Advantages of Infection Control Software
- Clinical Surveillance Innovation to Spur the Infection Surveillance Solutions Market
- Rising Need to Reduce Healthcare Costs to Propel Demand for Infection Surveillance Solutions
- Current & Required Healthcare Spending as % of GDP
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Rapidly Aging World Population to Drive Demand
- Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Digitalization of Healthcare and Technological Advancements
- Increasing Complexity of Healthcare Operations to Spur Demand for Infection Surveillance Solutions Market
- The Move to Cloud Gains Momentum
- Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Market Opportunities
- Percentage Share Breakdown of Global Deaths Linked to Air Pollution
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Long-Term Care Facilities by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 19: World Infection Surveillance Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Active Players in United States
- TABLE 20: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: USA 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
- Active Players in Canada
- TABLE 26: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: Canada 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Active Players in Japan
- TABLE 32: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: Japan 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Active Players in China
- TABLE 38: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: China Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: China 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: Europe 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Active Players in France
- TABLE 53: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: France Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: France 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Active Players in Germany
- TABLE 59: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: Germany 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
- Active Players in Italy
- TABLE 65: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: Italy 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Active Players in United Kingdom
- TABLE 71: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: UK 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
- Active Players in Rest of Europe
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: Rest of Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: Rest of Europe 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Active Players in Asia-Pacific
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Asia-Pacific Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Asia-Pacific 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
- Active Players in Rest of World
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2024 & 2030
- TABLE 92: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 93: Rest of World Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 94: Rest of World 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2024 & 2030
Companies Mentioned
- IBM Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Illumina, Inc.
- Cerner Corporation
- Ecolab, Inc.
- Gojo Industries, Inc.
- Epic Systems Corporation
- CenTrak, Inc.
- Iatric Systems, Inc.
- Harris Healthcare
- Perahealth, Inc.
- ABILITY Network Inc.
- Asolva, Inc.
- ICNet International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 254 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 670.2 Million |
| Forecasted Market Value ( USD | $ 1900 Million |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
